France · Source-listed medicine information

France / CIS 69445593

OPTRUMA 60 mg, comprimé pelliculé

comprimé pelliculé · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formcomprimé pelliculé
Routeorale
Ingredient entries2
CountryFrance

Product identity

At a glance

Authorisation holder
ELI LILLY NEDERLAND (PAY-BAS)
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 69445593

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for OPTRUMA 60 mg, comprimé pelliculé
IngredientStrength / referenceSource role
RALOXIFÈNE (CHLORHYDRATE DE)comprimé60 mgun compriméSAGroup 15
RALOXIFÈNE BASEcomprimé55,71 mgun compriméFTGroup 15

Pack references

Presentations (5)

plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s)

CIP13 3400934848667

Présentation active · Déclaration d'arrêt de commercialisation
plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : MEDIWIN Limited)

CIP13 3400949503599

Présentation active · Déclaration de commercialisation
plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s) (distributeur parallèle : MEDIWIN Limited)

CIP13 3400949503889

Présentation active · Déclaration de commercialisation
plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène de 28 comprimé(s) (distributeur parallèle : PHARMA LAB)

CIP13 3400949508044

Présentation active · Déclaration de commercialisation
plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène de 84 comprimé(s) (distributeur parallèle : PHARMA LAB)

CIP13 3400949508105

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 69445593 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →